Barry E. Greene, President and COO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 67,379 shares at $125.00 ($8.4M) on 2015-05-26, disclosed to the SEC on 2015-05-28.
Scheduled sale ($8.4M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |